← Eichor
Study identifier: NCT07600203 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Double-blind, Placebo-controlled Evaluation of the Effect of the Erchonia® EVRL on Chronic Jaw Pain Arising From TMJ

Condition: TMJ · TMJ Pain · TMD  ·  Sponsor: Erchonia Corporation

PhaseNA
Planned participants64
Who can joinAll sexes, 22 Years to 75 Years
Healthy volunteersNo

About this study

The purpose of this clinical study is to determine the effectiveness of the Erchonia EVRL, manufactured by Erchonia Corporation (the Company), in providing temporary relief of nociceptive musculoskeletal chronic jaw pain arising from temporomandibular joint (TMJ).

This description comes directly from the study's public registry record.

Talk to the study team

Travis Sammons  ·  888-242-0571  ·  tsammons@erchonia.com

Always discuss trial participation with your own doctor first.

Locations (1)

Acton Dental AssociatesActon, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07600203